The first paediatric patient for Dimerix’s ACTION3 phase III clinical trial into a rare kidney disease has been recruited at ...
Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric ...
The DMX-200 paediatric development plan aims to collect sufficient data for potential marketing approval in children aged over one in accordance with the US Food and Drug Administration (FDA ...